Susceptibility changes on preoperative acetazolamideloaded 7T MR quantitative susceptibility mapping predict post-carotid endarterectomy cerebral hyperperfusion

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.

From the Department of Neurosurgery (K.K., Y.A, K.F., M.K, T.K., K.Y., K.O.), the Centre for Division of Ultrahigh Field MRI, Institute for Biomedical Sciences (I.U., M.S), the Division of Molecular and Cellular Pharmacology, Department of Pathophysiology (S.F.), and the Cyclotron Research Center (K.T.), Iwate Medical University, Yahaba, Japan.